ATE395336T1 - Chinolinderivate zur verwendung als inhibitoren von mycobakterien - Google Patents
Chinolinderivate zur verwendung als inhibitoren von mycobakterienInfo
- Publication number
- ATE395336T1 ATE395336T1 AT05707886T AT05707886T ATE395336T1 AT E395336 T1 ATE395336 T1 AT E395336T1 AT 05707886 T AT05707886 T AT 05707886T AT 05707886 T AT05707886 T AT 05707886T AT E395336 T1 ATE395336 T1 AT E395336T1
- Authority
- AT
- Austria
- Prior art keywords
- mycobacteria
- inhibitors
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04075286 | 2004-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395336T1 true ATE395336T1 (de) | 2008-05-15 |
Family
ID=34833674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05707886T ATE395336T1 (de) | 2004-01-29 | 2005-01-28 | Chinolinderivate zur verwendung als inhibitoren von mycobakterien |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7790894B2 (de) |
| EP (1) | EP1713776B1 (de) |
| JP (1) | JP4919810B2 (de) |
| KR (1) | KR101160183B1 (de) |
| CN (1) | CN1910154B (de) |
| AP (1) | AP2321A (de) |
| AT (1) | ATE395336T1 (de) |
| AU (1) | AU2005210036B2 (de) |
| BR (1) | BRPI0507312A (de) |
| CA (1) | CA2554049C (de) |
| DE (1) | DE602005006744D1 (de) |
| EA (1) | EA011572B9 (de) |
| ES (1) | ES2306098T3 (de) |
| HK (1) | HK1099297A1 (de) |
| IL (1) | IL177101A (de) |
| MX (1) | MXPA06008596A (de) |
| NO (1) | NO337253B1 (de) |
| NZ (1) | NZ547614A (de) |
| UA (1) | UA83875C2 (de) |
| WO (1) | WO2005075428A1 (de) |
| ZA (1) | ZA200606291B (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2855B1 (en) * | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2684B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2685B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| EP2387564A1 (de) | 2009-01-15 | 2011-11-23 | Rutgers, The State University of New Jersey | Benzo[c]phenanthridine als antimikrobielle mittel |
| WO2010127307A1 (en) | 2009-04-30 | 2010-11-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| WO2011156626A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| CA2803890A1 (en) | 2010-06-25 | 2011-12-29 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| RU2486175C2 (ru) * | 2011-09-12 | 2013-06-27 | Закрытое Акционерное Общество "Фарм-Синтез" | Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений |
| US9822108B2 (en) | 2012-01-13 | 2017-11-21 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| EP2828245A1 (de) | 2012-03-21 | 2015-01-28 | Rutgers, The State University of New Jersey | Antimikrobiotika |
| AU2013254674B2 (en) | 2012-04-27 | 2017-02-02 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| KR102110366B1 (ko) | 2012-04-27 | 2020-05-14 | 얀센 파마슈티카 엔.브이. | 항균성 퀴놀린 유도체 |
| EP2909189B8 (de) | 2012-10-16 | 2017-04-19 | Janssen Pharmaceutica NV | Heteroarylverknüpfte chinolinyl-modulatoren von ror-gamma-t |
| WO2014062658A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
| CN105073729A (zh) | 2012-10-16 | 2015-11-18 | 詹森药业有限公司 | RORγt的苯基连接的喹啉基调节剂 |
| WO2015057626A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | QUINOLINYL MODULATORS OF RORyT |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| US9346782B2 (en) | 2013-10-15 | 2016-05-24 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| US10513528B2 (en) | 2016-02-25 | 2019-12-24 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| US10774093B2 (en) | 2017-03-30 | 2020-09-15 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998018326A1 (en) | 1996-10-28 | 1998-05-07 | Department Of The Army, U.S. Government | Compounds, compositions and methods for treating antibiotic-resistant infections |
| AU757059B2 (en) * | 1997-06-19 | 2003-01-30 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| US6103905A (en) | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| ES2201674T3 (es) * | 1998-01-26 | 2004-03-16 | Smithkline Beecham Plc | Derivados de quinolina con propiedades antibacterianas. |
| UA82198C2 (uk) * | 2002-07-25 | 2008-03-25 | Янссен Фармацевтика Н.В. | Хінолінові похідні та їх використання як мікобактеріальних інгібіторів, спосіб їх одержання, фармацевтична композиція на їх основі, проміжна сполука |
| NZ547277A (en) * | 2004-01-23 | 2009-08-28 | Janssen Pharmaceutica Nv | Substituted quinolines and their use as mycobacterial inhibitors |
-
2005
- 2005-01-28 UA UAA200605776A patent/UA83875C2/ru unknown
- 2005-01-28 BR BRPI0507312-0A patent/BRPI0507312A/pt not_active Application Discontinuation
- 2005-01-28 ES ES05707886T patent/ES2306098T3/es active Active
- 2005-01-28 JP JP2006550188A patent/JP4919810B2/ja active Active
- 2005-01-28 DE DE602005006744T patent/DE602005006744D1/de active Active
- 2005-01-28 KR KR1020067015159A patent/KR101160183B1/ko active IP Right Grant
- 2005-01-28 CN CN2005800031297A patent/CN1910154B/zh active Active
- 2005-01-28 AT AT05707886T patent/ATE395336T1/de active
- 2005-01-28 EP EP05707886A patent/EP1713776B1/de active Active
- 2005-01-28 MX MXPA06008596A patent/MXPA06008596A/es active IP Right Grant
- 2005-01-28 CA CA2554049A patent/CA2554049C/en active Active
- 2005-01-28 WO PCT/EP2005/050375 patent/WO2005075428A1/en active IP Right Grant
- 2005-01-28 NZ NZ547614A patent/NZ547614A/en unknown
- 2005-01-28 AU AU2005210036A patent/AU2005210036B2/en active Active
- 2005-01-28 AP AP2006003705A patent/AP2321A/xx active
- 2005-01-28 EA EA200601391A patent/EA011572B9/ru unknown
-
2006
- 2006-06-05 US US11/422,152 patent/US7790894B2/en active Active
- 2006-07-26 IL IL177101A patent/IL177101A/en active IP Right Grant
- 2006-07-28 ZA ZA200606291A patent/ZA200606291B/en unknown
- 2006-08-28 NO NO20063821A patent/NO337253B1/no unknown
-
2007
- 2007-06-15 HK HK07106483.4A patent/HK1099297A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA83875C2 (ru) | 2008-08-26 |
| EP1713776A1 (de) | 2006-10-25 |
| AU2005210036B2 (en) | 2010-12-23 |
| CN1910154A (zh) | 2007-02-07 |
| DE602005006744D1 (de) | 2008-06-26 |
| AP2006003705A0 (en) | 2006-08-31 |
| CA2554049A1 (en) | 2005-08-18 |
| CN1910154B (zh) | 2011-08-17 |
| NO337253B1 (no) | 2016-02-22 |
| EA011572B1 (ru) | 2009-04-28 |
| US7790894B2 (en) | 2010-09-07 |
| KR20070004597A (ko) | 2007-01-09 |
| JP4919810B2 (ja) | 2012-04-18 |
| NO20063821L (no) | 2006-08-28 |
| NZ547614A (en) | 2009-04-30 |
| AP2321A (en) | 2011-11-16 |
| ES2306098T3 (es) | 2008-11-01 |
| US20070299106A1 (en) | 2007-12-27 |
| JP2007519687A (ja) | 2007-07-19 |
| ZA200606291B (en) | 2008-02-27 |
| EA200601391A1 (ru) | 2006-12-29 |
| MXPA06008596A (es) | 2006-08-28 |
| IL177101A (en) | 2012-01-31 |
| CA2554049C (en) | 2012-12-18 |
| IL177101A0 (en) | 2006-12-10 |
| EP1713776B1 (de) | 2008-05-14 |
| AU2005210036A1 (en) | 2005-08-18 |
| KR101160183B1 (ko) | 2012-06-26 |
| BRPI0507312A (pt) | 2007-06-26 |
| EA011572B9 (ru) | 2018-01-31 |
| HK1099297A1 (en) | 2007-08-10 |
| WO2005075428A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE395336T1 (de) | Chinolinderivate zur verwendung als inhibitoren von mycobakterien | |
| DE602005013819D1 (de) | Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel | |
| ATE444068T1 (de) | Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren | |
| DE602006015297D1 (de) | 3-azetidincarbonsäure-derivate zur verwendung als immunsuppressiva | |
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| ATE524467T1 (de) | Neuartige aza-heterozyklen als kinase-inhibitoren | |
| ATE520671T1 (de) | Pyrimidin-harnstoff-derivate als kinase-hemmer | |
| DE602007013295D1 (de) | Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren | |
| ATE529421T1 (de) | Chinolinderivate als phosphodiesterase-hemmer | |
| DE602007008837D1 (de) | Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine | |
| ATE531705T1 (de) | Substituierte 2-chinolyloxazole geeignet als pde4 inhibitoren | |
| ATE452631T1 (de) | N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer | |
| ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren | |
| ATE446090T1 (de) | Thiadiazolidinone als gsk3-inhibitoren | |
| ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
| ATE472543T1 (de) | Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren | |
| ATE543816T1 (de) | Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase | |
| ATE478064T1 (de) | Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate | |
| ATE518860T1 (de) | Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren | |
| ATE441641T1 (de) | Isochinolinderivate als inhibitoren von rho- kinase | |
| DE602004025258D1 (de) | Aminotriazol-verbindungen als proteinkinase-hemmer | |
| ATE530545T1 (de) | Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate | |
| ATE521607T1 (de) | Piperidinderivate als renin-inhibitoren | |
| DE602005014646D1 (de) | Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1713776 Country of ref document: EP |